The Claim
Compliance with sulforaphane supplementation is associated with a statistically significant dose-dependent reduction in the bronchial Ki-67 index.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Higher adherence to sulforaphane supplements is linked to a measurable decrease in the Ki-67 marker in bronchial tissue, which indicates reduced cell proliferation.
See the scientific wording
There was a statistically significant dose-response relationship between sulforaphane supplement compliance and reduction in bronchial Ki-67 index, suggesting that adherence to the regimen enhances the biological effect.
Sulforaphane enters cells in the airways and turns on a protective system that cleans up harmful chemicals and reduces damage to DNA. This causes the cells to stop multiplying abnormally, which lowers the number of cells showing signs of uncontrolled growth.
What the research says
1 studyPeople who took the sulforaphane supplement more regularly had a bigger drop in a marker of abnormal cell growth in their airways, meaning taking it consistently made it work better.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.